ICCS 2025 | Philadelphia, PA

Home
Course & Meeting Program

Course & Meeting Program

Please find the 2025 Meeting & Course Program below.

The course will take place on Friday and finish at noon (12pm) on Sunday.
The meeting will then start on Sunday afternoon and finish on Tuesday.

All program times are listed in the Eastern Time zone.

View Summary Only

Monday, September 29th

7:00 - 8:00 AM
Ancillary Event

SPECIAL SESSION - ICCS CAREER LAB
Chair/Organizer: Fabienne Lucas

Commonwealth A1

7:30 - 5:30 PM
Break

MEETING REGISTRATION

Foyer

8:00 - 8:15 AM
Break

BREAKFAST

Millennium Hall

8:15 - 8:30 AM
Meeting

BUSINESS MEETING - OPEN TO ALL ICCS MEMBERS

Commonwealth BCD

8:30 - 11:30 AM
Plenary

PLENARY SESSION 2 - TOPICS IN CELL AND IMMUNE THERAPY
Chair/Organizer: Cara Shirai, Paul Mead

Commonwealth BCD

8:30

CSI Case
Wei Cui.

8:45

Flow Cytometric Detection of CAR T Cells: Reagent Selection, Assay Design, Reporting, and Clinical Relevance
Sa Wang.

9:20

Residual Disease Detection Post-Immunotherapy: Navigating Perils and Pitfalls
Erik Ames.

9:50

Coffee Break
.

10:20

Beyond Positive and Negative: Quantitative Flow Cytometry in Predicting CART Therapy Response inB-Cell Lymphomas
Jean Oak.

10:50

Revisiting Receptor Occupancy Assays: Can We Make Them Quantitative?
Virginia Litwin.

11:45 - 12:45 PM
Luncheon Workshop

LUNCH WORKSHOP 1: DIFFERENTIAL DIAGNOSIS OF CD5/CD10 NEGATIVE LYMPHOMA: IMMUNOPHENOTYPES AND INTEGRATED DIAGNOSTICS

Regency C1

Differential Diagnosis of CD5/CD10 Negative Lymphoma: Immunophenotypes and Integrated Diagnostics
Veronika Ecker .

LUNCH WORKSHOP 2: DESIGNING SMARTER LIS WORKFLOWS: BUILDING SYSTEMS THAT WORK FOR CLINICAL CYTOMETRISTS

Regency C2

11:45

Designing Smarter LIS Workflows: Building Systems That Work for Clinical Cytometrists - Part 1
Jean Oak.

12:15

Designing Smarter LIS Workflows: Building Systems That Work for Clinical Cytometrists - Part 2
Aaron Shaver.

LUNCH WORKSHOP 3: GREEN BY DESIGN: METRICS-DRIVEN APPROACHES TO SUSTAINABILITY IN CLINICAL FLOW CYTOMETRY LABORATORIES

Commonwealth A1

Green by Design: Metrics-Driven Approaches to Sustainability in Clinical Flow Cytometry Laboratories
Fabienne Lucas.

LUNCH WORKSHOP 4: MONOCYTE DISORDERS IN CHILDREN: JMML VS RASOPATHIES VS RALD

Commonwealth A2

Monocyte Disorders in Children: JMML vs RASopathies vs RALD
Rachel Mariani.

1:00 - 4:00 PM
Plenary

PLENARY SESSION 3 - FUTURE DIRECTIONS IN FLOW CYTOMETRY
Chair/Organizer: Veronica Nash , Alden Chesney

Commonwealth BCD

1:00

CSI CASE
Alexa Andre.

1:15

Best Original Paper Award - Cytometry B Clinical Cytometry
.

1:30

Technologies and Approaches for Emerging Translational and Clinical Applications
Scott Bornheimer .

2:10

End-to-End Innovation in Flow Cytometry Analysis of Human Clinical Trial Samples
Vilma Deckman .

2:50

Coffee Break
.

3:20

Imaging Flow Cytometry: Innovation from Discovery to the Clinic
Raffaello Cimbro.

4:00 - 5:30 PM
Posters/Exhibits

POSTER SESSION 2 (click to view) (click to close)

Millennium Hall

201

Standardising G6PD Screening By Flow Cytometry To Identify Carrier Females
Shreyam Acharya¹, Jasmita Dass¹, Shailja Singh², Ashok Jaiswal ¹, Richa Chauhan¹, Mukul Aggarwal¹, Shreeja Biswas², Swati Garg², Ganesh Kumar V¹, Tulika Seth¹, Anu Thukral¹, Vishal Gupta¹, Ravi Ranjan ¹, Rishi Dhawan¹, Pradeep Kumar¹, Manoranjan Mahapatra¹. ¹All India Institute of Medical Sciences, New Delhi, India.²Jawaharlal Nehru University, New Delhi, India

202

Immunophenotypic and Genomic Characterization of Precursor T-cell Neoplasms
Omar Z. Baba¹, Julia Rinck², Wei Liu¹, Yulei Shen¹, Elizabeth Wey¹, Juan Gomez-Gelvez¹, Kedar Inamdar¹, John Carey¹, Sharmila Ghosh¹. ¹Henry Ford Hospital, Detroit, MI, USA.²Wayne State University School of Medicine, Detroit, MI, USA

203

Efficient Workflow For High Quality Results From A 20-Color Acute Myeloid Leukemia Panel On A Spectral Flow Cytometer
Qing Chang, Emily Bui, Jun Deng. Cytek Biosciences, Inc., Fremont, CA, USA

204

Evaluation of Stage 0 Hematogones Using a 28-Marker Spectral B-cell Lymphoblastic Leukemia Panel
Patty M Davis¹, Will H Cherrington², David P Ng^{1, 2}, Jeffrey R Jacobsen^{1, 2}. ¹ARUP Institute for Clinical & Experimental Pathology, ARUP Laboratories, Salt Lake City, UT, USA.²Department of Pathology, University of Utah, Salt Lake City, UT, USA

205

Global Validation of a Pan-leukocyte Panel with Enumeration for Fresh Whole Blood
Heather Evans¹, David Ambrose¹, Natalie Carrol¹, Laurie Besson², Phuong Nguyen³, Tara Alvarez³, Nassouh Mourabet¹, Varun Dwivedi¹, Jonathan Ferrand³, Adam Cotty¹. ¹KCAS Bio, Lower Gwynedd, PA, USA.²KCAS Bio, Lyon, France.³Crux Biolabs, Bayswater, Australia

206

28-Color Spectral Flow Cytometry Platform for High-Dimensional Immune Profiling: Implementation in Clinical Trials of Blood Cancer and Insights into Autoimmune Diseases
Charlie Fu, Coral Zhao, Austin Carbajal, Naveen Dakappagari, Zeni Alfonso. Navigate Biopharma Inc, Carlsbad, CA, USA

207

Immunophenotypic Characterization of AML Blast Cells: A Pilot Study for Precision Therapeutic Targeting
SHALINI GAUTAM¹, GREG HAYES², CHANG An¹, CHINTAN JOBALIYA¹, DAVID AMBROSE¹, VARUN DWIVEDI¹, ADAM COTTY¹. ¹KCAS BIOANALYTICAL SERVICES, ambler, PA, USA.²KUROME THERAPEUTICS, CINCINATI, OH, USA.³KCAS BIOANALYTICAL SERVICES, ambler, PA, USA.⁴KCAS BIOANALYTICAL SERVICES, ambler, PA, USA.⁵KCAS BIOANALYTICAL SERVICES, ambler, PA, USA.⁶KCAS BIOANALYTICAL SERVICES, ambler, PA, USA.⁷KCAS BIOANALYTICAL SERVICES, ambler, PA, USA

208

Uncovering CAR T Cell Spatial Dynamics and Activation States with Integrated Spectral and Imaging Flow Cytometry
Lorena Hidalgo¹, Arthi Kannan¹, Samuel Shi¹, Hye-Won Song¹, Cynthia Sakofsky², Joseph Cantor¹, Stephanie Widmann¹, Aruna Ayer², Gisele Baracho¹. ¹BD Biosciencies, San Diego, CA, USA.²BD Bisociencies, Milpitas, CA

209

FINALIZATION OF THE QUANTITATIVE FLOW CYTOMETRY PROTOCOL FOR AUTOANTIBODIES CAUSING AUTOIMMUNE HEMOLYTIC ANEMIA
Triet Hy Van, Hien Thanh Dao, An Bao Thi Van, Dat Quoc Ngo, Mai Anh Thi Nguyen. University of Medicine and Pharmacy at HCMC, Ho Chi Minh, Vietnam

210

Blast Crisis of Chronic Myeloid Leukemia
Reshma Kulkarni¹, Zubaidah Al-Jumaili², Ying Pei². ¹Ben Taub Hospital, Health Harris, Houston, TX, USA.²Baylor College of Medicine, Houston, TX, USA

212

Performance evaluation of AI-Driven TBNK Analysis in Diagnostic Flow Cytometry
Paul E Mead¹, Baptiste Labarthe², Kamila Czechowska². ¹Department of Pathology, St. Jude Childrenâs Research Hospital, Memphis, TN, USA.²2Metafora Biosystems, Paris, France

213

Exploring 7AAD as an Indicator of Chromatin Accessibility in Stem and Progenitor Cells
Jennifer L. Salvo¹, Daniel R. Matson^{1, 2, 3}. ¹University of Wisconsin Hospitals and Clinics, Madison, WI, USA.²Department of Pathology and Laboratory Medicine, Madison, WI, USA.³Wisconsin Blood Cancer Research Institute, Madison, WI, USA.⁴University of Wisconsin Carbone Cancer Center Flow Cytometry Core, Madison, WI, USA

214

Development of a functional test for XIAP/XLP2 diagnosis
Nagako Stuart¹, Samuel Chiang^{1, 2}, Rebecca Marsh^{1, 2}. ¹Cincinnati Childrenâs Hospital Medical Center, Cincinnati, OH, USA.²University of Cincinnati, Cincinnati, OH, USA

215

Cut-off value of osmotic fragility and EMA binding test in hereditary spherocytosis diagnosis: challenging in a Thalassemic Country
Hien Thanh Dao¹, Triet Hy Van¹, Truong Nhat Trinh^{1, 2}, Son Thanh Tran^{1, 3}, Tuyet Bach Thi Tran¹, Mai Anh Thi Nguyen¹, Dat Quoc Ngo¹. ¹University of Medicine and Pharmacy at HCMC, Ho Chi Minh, Vietnam.²Pham Ngoc Thach University of Medicine, Ho Chi Minh, Vietnam.³MICOL Institute, Ho Chi Minh, Vietnam

216

Cytoplasmic staining of T cell receptor components enables efficient assessment of lineage and clonality in surface CD3-negative T cell neoplasms.
Aaron J Wilk, Gary Gitana, Jean Oak. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA

217

Native NK Cells And Their CAR-Transduced Derivatives Exhibit Differential Capacities In Pro-Inflammatory Cytokine Production And Killing
Samantha Bauchiero¹, Juliane Schlueter², Brandy Pinckney¹, Sharon Sen¹, Michael Kapinsky³, Sabine Huenecke². ¹Beckman Coulter Life Sciences, Indianapolis, IN, USA.²Department of Pediatrics, Goethe University Frankfurt, Frankfurt(M), Germany.³Beckman Coulter GmbH, Krefeld, Germany

218

Conversion of Lymphocyte Subsets Assay from 3 to 1 tube Format
Eugene V Ravkov¹, Garrin V Abbott¹, Jenifer D De Juan¹, Gudipaty Swapna¹, Leo Lin^{1, 2}. ¹ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA.²Clinical Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA

219

Development of a chronic lymphocytic leukemia (CLL) measurable residual disease (MRD) flow cytometry (FC) assay, independend of CD19 expression
Jessica Hughes¹, Joo Song¹, Alexey Danilov², Winston Lee¹, Matthew Mei², Lori Soma¹. ¹City of Hope Medical Center, Department of Pathology, Duarte, CA, USA.²City of Hope Medical Center, Department of Hematology, Duarte, CA, USA

220

Pseudokappa-Restricted Hematogones After Daratumumab Therapy: A Diagnostic Pitfall in B-Cell Clonality Assessment
Rajeswari Jayakumar, Kyle Tripp. Virginia Commonwealth University, Richmond, VA, USA

221

Flow cytometric detection of aggressive CD19 negative Philadelphia chromosome positive B-ALL: a case report and literature review
Daniel I Park¹, Serica J Hallstead¹, Megan E Kachur², Isaac E McCool¹. ¹Brooke Army Medical Center, San Antonio, TX, USA.²US Naval Hospital Okinawa, Okinawa, Japan

222

Developing objective criteria of antigen expression for Lineage Assignment in Acute Leukemia
Prashant Tembhare, Sneha Oommen, Jagruti Patil, Sitaram Ghogale, Nilesh Deshpande, karishma Girase, Gaurav Chatterjee, Sweta Rajpal, Shubham Pawar, Simpy Raj, Madhurima Paul, PG Subramanian. Hematopathology Department, ACTREC, Tata Memorial Centre, Navi Mumbai India

223

Comparing Outcomes in Precursor B-Lymphoblastic Leukemia Patients Based on Measurable Residual Disease Assessed by an Eight-Color Flow Cytometry Panel and ClonoSeq
Yuslina M Yusoff², Norazlina Azman ³, Joseph Tario1¹, Peter Maslak¹, You-Wen Qian¹. ¹Roswell Park Comprehensive Cancer Institute, Buffalo, NY, USA.²Cancer Research Centre, Selangor, Malaysia.³Tunku Azizah Hospital, Kuala Lumpur, Malaysia

224

Acute myeloid leukemia with chromosomal double minutes and c-MYC amplification exhibits unique immunophenotypic characteristics
Shanxiang Zhang, Zhenya Tang, Changqing Xia, Jeffrey Cannatella, Joseph Khoury. University of Nebraska Medical Center, Department of Pathology, Microbiology, and Immunology, Omaha, NE, USA

226

Integrated Machine Learning Analysis for Automatic Recognition of B-ALL MRD in Flow Cytometry List Mode Data
En-Ping Chu¹, Jen-Wei Wang¹, Fong-Ci Lin¹, Michael J. Borowitz², J. David Peske², Yu-Fen Wang^{1, 3}. ¹AHEAD Intelligence Ltd, Taipei Taiwan.²Johns Hopkins University School of Medicine, Department of Pathology, Baltimore, MD, USA.³AHEAD Medicine Corporation, San Jose, CA, USA

227

Artificial Intelligence-Based Screening of Paroxysmal Nocturnal Hemoglobinuria Clones: Development and Comparative Evaluation of Machine Learning Models
Felipe Furtado^{1, 2}, Alan Dias¹, Fernanda Resende¹, Camila Nobre¹, AndrÃ© Santos³, AdÃ¢mara FelÃcio⁴. ¹Sabin Medicina DiagnÃ³stica, BrasÃlia, Brazil.²Hospital da CrianÃ§a de BrasÃlia, BrasÃlia, Brazil.³Hospital do Amor, BrasÃlia, Brazil.⁴Universidade de SÃ£o Paulo / Esalq, BrasÃlia, Brazil

228

Gender Disparities in Cytometry Collaboration: A Longitudinal Publication Network Analysis (2004–2024)
S. Lucas Black¹, Fabienne Lucas². ¹CytoLogic Solutions, London, United Kingdom.²Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA

229

Simulated Detection of Circulating Tumor Cells Using Imaging Flow Cytometry and Machine Learning
Rodrigo Pestana Lopes, Supriya Ramachandran, Tri Le, Woodrow Lomas, Aaron Middlebrook. BD Biosciences, Milpitas, CA, USA

230

Impact of Specimen Processing Methods and Processing Delays on Immune Profiling using High-Complexity Flow Cytometry Assays in clinical trials
Md Mahmudul Hasan, Priya K Shah, Dilanjan Anketell, Angela Nalwoga, Qi Wu, Radhika Kulkarni, Mariana Mata, Liam Murphy, Deyi Zhang, Shannon McGrath, Paul C Trampont. Moderna Global Clinical Biomarker Laboratory, Norwood, MA, USA

231

Optimizing Imaging Flow Cytometry with BD CellView™ Technology for Higher-Parameter Data Generation
Rodrigo Pestana Lopes¹, Lorena Hidalgo², Jesus Olvera², Mirko Corselli², Stephanie Widmann², Aaron Tyznik¹. ¹BD Biosciences, Milpitas, CA, USA.²BD Biosciences, San Diego, CA, USA

232

Enhancing PNH Research Precision: Optimizing Antibody Cocktail Prep with the Fontus™ Workstation
Vien Nguyen ¹, David PILLON¹, Isabelle Viellard-Pelve², Anagha Divekar¹. ¹BioLegend Inc, San Diego, CA, USA.²Revvity Health Sciences, Inc, Hopkinton, MA, USA

233

Ready-to-Use Antibody Cocktails including Brilliant Violet Dyes for Flow Cytometry
Tunde Mester, Shawna Shirley, Anagha Divekar, Xifeng Yang, Carsten Wiethe. BioLegend Inc, San Diego, CA, USA

234

CellMek SPS Instrument Antibody Auto-Cocktailing Performance
Xizi (Daisy) Dai, Xue Wen, Jessica Ashbaugh, Juan Fernandez De Castro, Ernesto Staroswiecki. Beckman Coulter Life Sciences, Miami, FL, USA

235

A Case of “Triclonal” T-cell Prolymphocytic Leukemia
Nicole So^{1, 2}, Ahmad Al-Attar², Katelynn E. Davis², Nidhi Aggarwal², Majd Jawad², Erika Moore², Bryan A. Rea², Sara A. Monaghan², Nana P. Matsumoto². ¹Tufts School of Medicine, Boston, MA, USA.²Department of Pathology - University of Pittsburgh Medical Center, Pittsburgh, PA, USA

236

When Sézary Syndrome Resembles Angioimmunoblastic T-cell Lymphoma: A Diagnostic Challenge
Dina S Soliman^{1, 2, 3}, Omnya Abdalla¹, Suhair Hassan¹. ¹Hamad medical corporation, Doha, Qatar.²National Cancer Institute, Cairo University, Cairo, Egypt.³Weill Cornell Medicine-Qatar, Doha, Qatar

237

Chronic Lymphocytic Leukemia with an Unusual Immunophenotype
Channah Mills, Christina Ryan, Jeannie Muir. Walter Reed National Military Medical Center, Bethesda, MD, USA

238

nTFHL with unique double positive T cell phenotype
Subhashis Mitra, Audun Saterbak , Paul Meyer. University of Iowa Health Care, Iowa City, IA, USA

239

35 Color Flow Cytometry Panel to Study Human T Cell Phenotype and Function in Clinical Trials
Xiao Li, Ciara Gimblet-Ochieng, Taryn Mockus, Esther Perez Garcia, Ruth Barnard, Veronica Nash, Vilma Decman. GSK, Collegeville, PA, USA

240

Myoepithelial Carcinoma Mimicking Plasma Cell Dyscrasia
Nourhan Ibrahim, Hanadi El Achi, Jacob Armstrong, Amer Wahed, Andy Nguyen, Brenda Mai. The University of Texas Health Science Center, Houston, TX, USA

7:00 - 9:30 PM
Social Event

SOCIAL NETWORKING EVENING

Off-Site

Program

Program

Course & Meeting Program

Please find the 2025 Meeting & Course Program below. The course will take place on Friday and finish at noon (12pm) on Sunday. The meeting will then start on Sunday afternoon and finish on Tuesday. All program times are listed in the Eastern Time zone.

Monday, September 29th

Please find the 2025 Meeting & Course Program below.

The course will take place on Friday and finish at noon (12pm) on Sunday.
The meeting will then start on Sunday afternoon and finish on Tuesday.

All program times are listed in the Eastern Time zone.